SeqSMART

✨ Happy New Year 2026! ✨ As we begin this new year, we would like to thank our community, partners, and clients for your trust and support. We wish you a year filled with health, success, innovation, and scientific breakthroughs. 🎁 Our New Year gift to you: We are excited to share our #Sanger_Sequencing Module, now officially introduced on YouTube and available completely FREE of charge for all users — and it will remain free. 🔬 Why this module matters - Designed for accurate and efficient #Sanger_sequencing variant analysis Built with a robust, expert-driven backend - Clean, intuitive interface tailored for genomic professionals - Seamlessly integrates into a structured interpretation workflow - This module reflects our belief that high-quality genomic tools should be accessible, reliable, and easy to use. 🌐 Access the module here: 👉 https://lnkd.in/e-etVcMY 🎥 Watch the full introduction video via the link in this post: https://lnkd.in/eyvY7F5U 💬 We would love your feedback Your insights help us improve and shape SeqSMART’s future. Please try the module, share your thoughts, and tell us how we can make it even better — we genuinely enjoy and value your feedback. Here’s to a year where science, innovation, and expertise meet 🚀 #HappyNewYear #SeqSMART #SangerSequencing #Genomics #Bioinformatics #MolecularDiagnostics #OpenScience #FreeTools

Strengthening Data Protection & GDPR Compliance at SeqSMART At SeqSMART, safeguarding genomic data and ensuring full compliance with #GDPR and international regulations is a core commitment — one that grows more important as our platform expands globally. To strengthen this foundation, we’re proud to announce our strategic collaboration with AryaTech, Dr. Mohammad Hossein Heidarpour, a Swiss legal-technology boutique specializing in resolving technology-related disputes and guiding startups through complex cross-border regulatory landscapes. AryaTech brings nearly two decades of legal experience combined with cutting-edge research in blockchain, artificial intelligence, and technology risk analysis. Their expertise spans: Technology dispute resolution, mediation, and high-tech contract arbitration Blockchain & AI risk assessment, with regulatory impact and compliance roadmaps Cross-border structuring & governance, supporting multi-jurisdictional compliance Legal advisory for high-tech startups, investors, and innovation-driven platforms With their deep understanding of the intersection between law, technology, and innovation, AryaTech strengthens SeqSMART’s ability to operate securely, transparently, and in full compliance with GDPR and international standards. This partnership reinforces our dedication to protecting user rights, enhancing data security, and ensuring a trustworthy environment for genomic analysis — today and as we scale. SeqSMART: Where genomics meets the future — securely. #SeqSMART #GDPR #DataProtection #PrivacyByDesign #Genomics #DigitalHealth #Compliance #HealthcareInnovation

SeqSMART Is Live! Experience the First Version of Our Variant Classification Tool https://www.seqsmart.com/ We’re excited to announce that SeqSMART, where genomics meets future, is now live! 🎉 After months of #innovation, #development, and #refinement, the first version of the SeqSMART #Variant_Classification_Tool is officially available. Built upon an improved #ACMG framework and powered by an #AI_driven algorithm, SeqSMART delivers a smarter, more consistent, and more transparent approach to variant interpretation. This release marks just the beginning. In the coming months, we’ll expand the platform with new modules, including #Somatic_Variant_Classification, #Case_Manager, #Sanger_Sequencing_Analysis and additional advanced analysis tools. As this is our first release, we’re continuously refining the system, and your expert feedback matters. 💬 If you explore SeqSMART, please share your observations, thoughts, or suggestions. Your input will help us enhance and optimize the platform for the genomic community. ✨ SeqSMART isn’t just another analysis tool, it’s the start of a smarter way to interpret genomic data. #SeqSMART #Genomics #PrecisionMedicine #VariantInterpretation #Innovation #HealthcareTechnology

The ACMG guidelines have been the cornerstone of variant interpretation for nearly a decade. But as many experts know, applying them consistently is not always straightforward. Ambiguities, variable thresholds, and context-dependent rules can lead to different conclusions for the same variant. At SeqSMART, we believe that the future of variant interpretation requires more precision, more adaptability, and more intelligence. That’s why we’ve developed an improved #ACMG classification framework — one that integrates curated pathogenic variant datasets, gene–disease correlations, and Bayesian modelling to deliver more reliable and consistent results. This is how SeqSMART turns complexity into clarity. ########################################### And the journey is just beginning: this October, we will launch the first phase of SeqSMART. #Genomics #ACMG #SeqSMART #PrecisionMedicine #HealthcareInnovation

The ACMG - American College of Medical Genetics and Genomics, 2015 guidelines state: “Absent from controls (or at extremely low frequency if recessive)” (PM2). But what exactly does “extremely low frequency” mean? Is it 1%? 0.1%? 0.01%? Or even less? This ambiguity creates inconsistencies in variant interpretation — different labs may reach different conclusions for the same variant. At SeqSMART, we address this gap with a new approach: - A curated set of known (likely) pathogenic variants for each gene - Integration of gene–disease correlation and mode of inheritance - A Bayesian-based algorithm to predict the most accurate threshold of pathogenicity using population databases like gnomAD and ExAC This is how SeqSMART goes beyond standard interpretation to deliver a more precise, consistent, and scalable solution for genomic analysis. This is just one example of how we’re reshaping variant interpretation. SeqSMART is not just another tool — it’s the future of genomic analysis. #Genomics #ACMG #SeqSMART #PrecisionMedicine #VariantInterpretation

SeqSMART is loading ..... The future of medicine lies in understanding our DNA. At SeqSMART, we are building the bridge between raw genomic data and actionable insights. We’re excited to officially introduce SeqSMART, where genomics meets future. Our mission is to make genomic data analysis smarter, faster, and more accessible for medical geneticist, researchers, clinicians, and innovators. Over the coming weeks, we’ll share how SeqSMART empowers experts to unlock the full potential of genomic data, from variant interpretation to personalized insights. Stay tuned for our upcoming posts as we reveal more about our platform, services, and vision. Follow us here to be part of the future of genomics. #Genomics #PrecisionMedicine #Innovation #SeqSMART #FutureOfHealthcare

SeqSMART is loading ..... The future of medicine lies in understanding our DNA. At SeqSMART, we are building the bridge between raw genomic data and actionable insights. We’re excited to officially introduce SeqSMART, where genomics meets future. Our mission is to make genomic data analysis smarter, faster, and more accessible for medical geneticist, researchers, clinicians, and innovators. Over the coming weeks, we’ll share how SeqSMART empowers experts to unlock the full potential of genomic data, from variant interpretation to personalized insights. Stay tuned for our upcoming posts as we reveal more about our platform, services, and vision. Follow us here to be part of the future of genomics. #Genomics #PrecisionMedicine #Innovation #SeqSMART #FutureOfHealthcare